X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20) 20
mutation (14) 14
female (11) 11
oncology (10) 10
index medicus (9) 9
dna mutational analysis (7) 7
lung neoplasms - genetics (7) 7
male (7) 7
middle aged (7) 7
aged (6) 6
adult (5) 5
animals (5) 5
article (5) 5
cancer (5) 5
egfr mutations (5) 5
lung neoplasms - drug therapy (5) 5
mutation, missense (5) 5
receptor, epidermal growth factor - genetics (5) 5
tumors (5) 5
adenocarcinoma - genetics (4) 4
base sequence (4) 4
breast neoplasms - genetics (4) 4
cell line, tumor (4) 4
expression (4) 4
gefitinib (4) 4
gene amplification (4) 4
lung cancer (4) 4
mice (4) 4
quinazolines - therapeutic use (4) 4
research (4) 4
somatic mutations (4) 4
treatment outcome (4) 4
acquired-resistance (3) 3
aged, 80 and over (3) 3
amino acid sequence (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
epidermal growth factor (3) 3
erlotinib (3) 3
heterozygote (3) 3
kinases (3) 3
molecular sequence data (3) 3
mutation - genetics (3) 3
neoplasm staging (3) 3
neoplasms - genetics (3) 3
phase-ii trial (3) 3
prognosis (3) 3
protein kinase inhibitors - therapeutic use (3) 3
receptor, epidermal growth factor - metabolism (3) 3
sequence deletion (3) 3
1100delc (2) 2
adenocarcinoma (2) 2
adenocarcinoma - drug therapy (2) 2
adenocarcinoma - metabolism (2) 2
amino acid substitution (2) 2
analysis (2) 2
antineoplastic agents - therapeutic use (2) 2
biomarkers, tumor (2) 2
biomarkers, tumor - metabolism (2) 2
breast (2) 2
breast cancer (2) 2
breast neoplasms - mortality (2) 2
breast neoplasms - pathology (2) 2
breast-cancer (2) 2
cancer therapies (2) 2
carcinoma, squamous cell - drug therapy (2) 2
care and treatment (2) 2
case-control studies (2) 2
cell biology (2) 2
cell cycle proteins - metabolism (2) 2
cell lung-cancer (2) 2
cell survival (2) 2
cell transformation, neoplastic (2) 2
checkpoint kinase 2 - genetics (2) 2
chek2 (2) 2
chek2-asterisk-1100delc (2) 2
chemotherapy (2) 2
cluster analysis (2) 2
codon (2) 2
colorectal cancers (2) 2
combination (2) 2
dna mutational analysis - methods (2) 2
dna-damage (2) 2
down-regulation (2) 2
efficacy (2) 2
egfr (2) 2
erbb receptors - genetics (2) 2
europe - epidemiology (2) 2
exons (2) 2
gene (2) 2
gene expression (2) 2
gene expression profiling (2) 2
gene expression regulation, neoplastic (2) 2
gene mutations (2) 2
genetic association studies (2) 2
genetics & heredity (2) 2
genomes (2) 2
genomics (2) 2
genotype (2) 2
growth-factor-receptor (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2004, Volume 350, Issue 21, pp. 2129 - 2139
Journal Article
Journal Article
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 12/2007, Volume 121, Issue 12, pp. 2661 - 2667
Journal Article
Cancer Research, ISSN 0008-5472, 04/2006, Volume 66, Issue 7, pp. 3452 - 3455
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2004, Volume 350, Issue 21, p. 2129
A study conducted to search for mutations in the epidermal growth factor receptor (EGFR) gene in primary tumors from patients with non-small-cell lung cancer.... 
Lung cancer, Non-small cell | Drug therapy | Analysis | Mutation (Biology)
Journal Article
The American Journal of Human Genetics, ISSN 0002-9297, 05/2017, Volume 100, Issue 5, pp. 751 - 765
Journal Article
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2017, Volume 54, pp. 43 - 57
Highlights • Efficacy benefits are observed with EGFR-inhibitors for lung SqCC and SCCHN. • Biomarkers of response to EGFR-inhibitors in lung SqCC and SCCHN... 
Hematology, Oncology and Palliative Medicine | Squamous histology | Biomarkers | Head and neck cancer | EGFR inhibition | Disease management | Lung cancer | CHEMOTHERAPY PLUS CETUXIMAB | OPEN-LABEL | HUMAN-PAPILLOMAVIRUS | OROPHARYNX CANCER | PHASE-III TRIAL | RECEPTOR-TYROSINE KINASE | ONCOLOGY | 2ND-LINE TREATMENT | ERLOTINIB MAINTENANCE THERAPY | 1ST-LINE THERAPY | RETROSPECTIVE ANALYSIS | Lung Neoplasms - drug therapy | ErbB Receptors - antagonists & inhibitors | ErbB Receptors - metabolism | Neoplasms, Squamous Cell - epidemiology | Carcinoma, Squamous Cell - epidemiology | Antibodies, Monoclonal - pharmacology | Humans | ErbB Receptors - genetics | Head and Neck Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - epidemiology | Treatment Outcome | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - drug therapy | Lung Neoplasms - epidemiology | Head and Neck Neoplasms - epidemiology | Neoplasms, Squamous Cell - drug therapy | Biomarkers, Tumor - metabolism | Biomarkers, Tumor - genetics | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Molecular Targeted Therapy - methods | Prevention | Cancer | Medical research | Squamous cell carcinoma | Epidermal growth factor | Analysis | Medicine, Experimental | Development and progression
Journal Article